Clinical Trials Update: Nov. 22, 2006
Schizophrenia and Schizoaffective Disorders Migraine and Cluster Headaches Healthy Patient Studies
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Schizophrenia and Schizoaffective Disorders
This study will compare an investigational agent to a marketed medication to treat people with negative symptoms of schizophrenia for six months. Volunteers at least 18 who have a current primary diagnosis of negative symptoms of schizophrenia and have been clinically stable for the past five months may be eligible. People with clinically significant laboratory abnormalities, a history of substance abuse or dependence within the past five months, or concurrent psychiatric disorders other than schizophrenia will not be included in the study.
The research sites are located across the United States.
Migraine and Cluster Headaches
This is a double-blind, placebo controlled study for adults with frequent migraine headaches. Candidates 18-65 who have a history of migraine of at least one year and are willing to complete headache diaries throughout the study may qualify. Following a screening period, qualified participants will be randomized to an approved medication or placebo that will be taken twice daily. The study will last approximately 10 months with 10 clinic visits. Compensation for time and travel will be provided.
The research site is in Palm Beach Gardens, Fla.
Healthy Patient Studies
Healthy men and women who are 65 or older, non-smokers, and willing to stay at a clinic for nine overnights and one outpatient daytime visit are needed for this research study. Volunteers may receive up to $2393 upon study completion.
The research site is in Evansville, IN.
Copyright 2006 Thomson CenterWatch. All rights reserved.